Prostate News and Research

RSS

PSA screening for prostate cancer is not effective, report researchers

According to a new study, the one-off PSA screening test for prostate cancer does not save lives of asymptomatic men.

7 Mar 2018

Multimodal treatment approach enhances long-term survival in men with metastatic prostate cancer

UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer.

5 Mar 2018

New PET imaging agent allows early detection of prostate cancer relapse

An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear medicine imaging agent targeting copper accumulation in tumors can detect prostate cancer recurrence early in patients with biochemical relapse (rising prostate-specific antigen [PSA] level).

5 Mar 2018

USC scientists use metal-detection technique to study cancer

Metal detection has helped mining companies strike gold and airport security identify passengers who are a potential threat. Now USC scientists have pushed its use into another realm: studying cancer.

28 Feb 2018

UC Riverside researchers discover way to halt cancer metastasis

A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

23 Feb 2018

Rare immune cell may prove to be potent weapon in fighting against cancer

One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

23 Feb 2018

Computerized tissue-imaging may help predict early recurrence of lung cancer

Case Western Reserve and Cleveland Clinic are leading development of a computerized tissue-imaging program that could soon help identify which lung cancer patients are likely to face an earlier recurrence of the disease.

20 Feb 2018

New genetic risk score could help guide screening decisions for prostate cancer

One of the biggest challenges in treating prostate cancer is distinguishing men who have aggressive and potentially lethal disease from men whose cancer is slow-growing and unlikely to metastasize.

20 Feb 2018

Scientists develop fluorescent probe to identify cancer stem cells

Cells with stem-cell characteristics appear to be especially important in the formation and metastasis of tumors. Scientists have now developed a universal fluorescent probe for these “cancer stem cells”. As reported in the journal Angewandte Chemie, this dye also selectively kills off the cells.

19 Feb 2018

Fathers maybe passing on ovarian cancer genes to their daughters

According to a team of researchers from the Roswell Park Cancer Institute, a new gene mutation could be responsible for ovarian cancers and this could be passed on from fathers to their daughters.

16 Feb 2018

Ultra-processed foods linked to increased risk of cancers

A new study by French researchers links ultra-processed food consumption and cancer. Ultra-processed foods include mass produced chicken and fish nuggets, meatballs, breads, buns, crisps, chocolates, sweets, cakes, instant noodles and soups, frozen and ready to eat meals, sodas, sweetened drinks etc.

16 Feb 2018

Study reveals the association between ultra-processed foods and cancer

Researchers in Brazil and France have discovered the possible correlations between the intake of highly processed foods and risk of overall cancer, including prostate, breast, and bowel (colorectal) cancers.

15 Feb 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018

Scientists unravel immune cascade that drives tissue damage, complications in chlamydia infections

Closing a critical gap in knowledge, Harvard Medical School scientists have unraveled the immune cascade that fuels tissue damage and disease development in chlamydia infection - the most common sexually transmitted disease in the United States.

13 Feb 2018

Patients with Huntington's have lesser cancer than general population

Patients with Huntington's disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.

12 Feb 2018

Researchers refine two innovative surgery techniques for effective treatment of lymphedema

Lymphoedema is fluid retention in the tissue caused by damage to the lymphatic system and is one of the most serious side-effects of cancer operations.

12 Feb 2018

Indigenous people exposed to oil spills have harmful metal contaminants in their body, study finds

People from two indigenous communities in the Peruvian Amazon who live close to the country's longest oil pipeline have mercury, cadmium and lead in their bodies at concentrations that could be harmful to their health.

11 Feb 2018

Study of men with inherited DNA repair mutations opens new therapeutic avenues in prostate cancer

Selected by the American Society of Clinical Oncology to first outing during its Genitourinary Cancers Symposium, Translating Evidence to Multidisciplinary Care, February 8 - 10 (San Francisco, USA), Joaquin Mateo, Principal Investigator of VHIO's recently created Prostate Cancer Translational Research Group, will today reveal findings from a retrospective and international study showing for the first time that patients with inherited DNA repair mutations benefit from standard therapies in a similar way to other metastatic prostate cancer patients.

9 Feb 2018

Black patients found to be underrepresented in prostate cancer clinical trials

Clinical trials can offer patients access to cutting-edge treatments with the potential to extend their survival and shape the standard of care in the future.

8 Feb 2018

New algorithm provides personalized treatment approach for patients with metastatic spine cancer

Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a paucity of guidance for effectively providing care and minimizing pain.

8 Feb 2018